

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 8.72313195 |
| 2 | complement activation (GO:0006956) | 8.10075393 |
| 3 | glomerular filtration (GO:0003094) | 7.11406492 |
| 4 | renal filtration (GO:0097205) | 6.41717298 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.38311091 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.27054899 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.20675692 |
| 8 | protein activation cascade (GO:0072376) | 5.96839413 |
| 9 | regulation of respiratory burst (GO:0060263) | 5.77850074 |
| 10 | antibacterial humoral response (GO:0019731) | 5.45783686 |
| 11 | antimicrobial humoral response (GO:0019730) | 5.37119454 |
| 12 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 4.95423417 |
| 13 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 4.95423417 |
| 14 | Fc-gamma receptor signaling pathway (GO:0038094) | 4.95423417 |
| 15 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 4.93619754 |
| 16 | regulation of cellular extravasation (GO:0002691) | 4.89914692 |
| 17 | humoral immune response (GO:0006959) | 4.82877551 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.68590138 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.12463135 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.05325081 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05325081 |
| 22 | detection of bacterium (GO:0016045) | 3.94077629 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.88527202 |
| 24 | detection of other organism (GO:0098543) | 3.85675268 |
| 25 | retina homeostasis (GO:0001895) | 3.71772895 |
| 26 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.68057531 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.66612796 |
| 28 | regulation of antigen processing and presentation (GO:0002577) | 3.55654533 |
| 29 | cellular response to type I interferon (GO:0071357) | 3.39552649 |
| 30 | type I interferon signaling pathway (GO:0060337) | 3.39552649 |
| 31 | response to type I interferon (GO:0034340) | 3.36795793 |
| 32 | positive regulation of pseudopodium assembly (GO:0031274) | 3.36169814 |
| 33 | NIK/NF-kappaB signaling (GO:0038061) | 3.34577605 |
| 34 | angiotensin maturation (GO:0002003) | 3.33681240 |
| 35 | positive regulation of antigen processing and presentation (GO:0002579) | 3.32002055 |
| 36 | chronic inflammatory response (GO:0002544) | 3.30636438 |
| 37 | germinal center formation (GO:0002467) | 3.29100811 |
| 38 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.24868448 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.22242100 |
| 40 | eosinophil chemotaxis (GO:0048245) | 3.20549512 |
| 41 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.15558057 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14806705 |
| 43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14806705 |
| 44 | modulation by symbiont of host immune response (GO:0052553) | 3.14806705 |
| 45 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14806705 |
| 46 | modulation by symbiont of host defense response (GO:0052031) | 3.14806705 |
| 47 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14806705 |
| 48 | B cell mediated immunity (GO:0019724) | 3.11425626 |
| 49 | negative regulation of myotube differentiation (GO:0010832) | 3.09570099 |
| 50 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04230999 |
| 51 | cellular response to interferon-gamma (GO:0071346) | 2.99363990 |
| 52 | regulation of pseudopodium assembly (GO:0031272) | 2.98906111 |
| 53 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.97768961 |
| 54 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.97737413 |
| 55 | macrophage activation involved in immune response (GO:0002281) | 2.96764773 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93473148 |
| 57 | eosinophil migration (GO:0072677) | 2.89714036 |
| 58 | detection of external biotic stimulus (GO:0098581) | 2.87756127 |
| 59 | response to interferon-gamma (GO:0034341) | 2.87622235 |
| 60 | dendritic cell chemotaxis (GO:0002407) | 2.87089261 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 2.85587939 |
| 62 | regulation of integrin activation (GO:0033623) | 2.84099444 |
| 63 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83691049 |
| 64 | production of molecular mediator of immune response (GO:0002440) | 2.79152482 |
| 65 | GDP-mannose metabolic process (GO:0019673) | 2.75093141 |
| 66 | intestinal absorption (GO:0050892) | 2.71745339 |
| 67 | respiratory burst (GO:0045730) | 2.66073994 |
| 68 | myeloid dendritic cell differentiation (GO:0043011) | 2.64358932 |
| 69 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.62814612 |
| 70 | protein-chromophore linkage (GO:0018298) | 2.60591213 |
| 71 | regulation of necrotic cell death (GO:0010939) | 2.58319987 |
| 72 | interferon-gamma secretion (GO:0072643) | 2.58228006 |
| 73 | immune response-activating signal transduction (GO:0002757) | 2.57406592 |
| 74 | regulation of guanylate cyclase activity (GO:0031282) | 2.55002073 |
| 75 | activation of immune response (GO:0002253) | 2.53199629 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.53031859 |
| 77 | regulation of tolerance induction (GO:0002643) | 2.52194558 |
| 78 | regulation of regulatory T cell differentiation (GO:0045589) | 2.52173574 |
| 79 | T-helper 1 type immune response (GO:0042088) | 2.51700559 |
| 80 | virion attachment to host cell (GO:0019062) | 2.50457485 |
| 81 | adhesion of symbiont to host cell (GO:0044650) | 2.50457485 |
| 82 | peptide catabolic process (GO:0043171) | 2.49969743 |
| 83 | positive regulation of T cell migration (GO:2000406) | 2.49105404 |
| 84 | dendritic cell migration (GO:0036336) | 2.48012921 |
| 85 | neutrophil activation involved in immune response (GO:0002283) | 2.47601603 |
| 86 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.42564014 |
| 87 | oligosaccharide biosynthetic process (GO:0009312) | 2.42458415 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 2.42378495 |
| 89 | regulation of T cell migration (GO:2000404) | 2.41676634 |
| 90 | regulation of gamma-delta T cell activation (GO:0046643) | 2.41320065 |
| 91 | detection of biotic stimulus (GO:0009595) | 2.40412785 |
| 92 | positive regulation of type 2 immune response (GO:0002830) | 2.40221055 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 2.39322749 |
| 94 | T cell costimulation (GO:0031295) | 2.37740910 |
| 95 | regulation of vitamin metabolic process (GO:0030656) | 2.36825700 |
| 96 | lymph node development (GO:0048535) | 2.36684955 |
| 97 | defense response to Gram-negative bacterium (GO:0050829) | 2.36671887 |
| 98 | positive thymic T cell selection (GO:0045059) | 2.36519652 |
| 99 | epithelial structure maintenance (GO:0010669) | 2.35917971 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.1869102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.95807907 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.06769201 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.76194806 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.16273700 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.10362504 |
| 6 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.52427108 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.48522882 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.37656172 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37007411 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35381671 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.23959392 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13213248 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12118120 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97514569 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95859559 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91160250 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90652844 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84315531 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.81460614 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.80369533 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77231887 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75424941 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74339563 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71655722 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69905143 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63359045 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63199118 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.62656044 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61497836 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59852164 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56602657 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50394055 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46066990 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42652547 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42139567 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40317875 |
| 37 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.39701881 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38869829 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36767728 |
| 40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.36717630 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34633756 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34324238 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.33444755 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31170246 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30540237 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29596535 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29554360 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28319250 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27699548 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27420142 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26478877 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26406151 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.23964323 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.23452952 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22285625 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22101552 |
| 57 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21571834 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21473333 |
| 59 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19416725 |
| 60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18100375 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17823255 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17054545 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16296899 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11044727 |
| 65 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10994565 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10971930 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10971182 |
| 68 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09627820 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.07560534 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07385110 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05190402 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05015334 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04278670 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04028078 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02671390 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01741789 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01546992 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01354784 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00431556 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98784324 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98114048 |
| 82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98112935 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97860350 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 0.96922096 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94670735 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94593563 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94475134 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93918266 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93371032 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92942122 |
| 91 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.92695632 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92507010 |
| 93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92121758 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92073980 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91199057 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89112583 |
| 97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87706510 |
| 98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85993426 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85661547 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85570760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.27487035 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.31586204 |
| 3 | MP0003303_peritoneal_inflammation | 3.29083088 |
| 4 | MP0010155_abnormal_intestine_physiology | 3.21206746 |
| 5 | MP0003436_decreased_susceptibility_to | 3.08309993 |
| 6 | MP0005387_immune_system_phenotype | 2.97981343 |
| 7 | MP0001790_abnormal_immune_system | 2.97981343 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.82998267 |
| 9 | MP0001800_abnormal_humoral_immune | 2.54242337 |
| 10 | MP0005025_abnormal_response_to | 2.49755837 |
| 11 | MP0009785_altered_susceptibility_to | 2.39864461 |
| 12 | MP0003866_abnormal_defecation | 2.30711239 |
| 13 | MP0005671_abnormal_response_to | 2.27345340 |
| 14 | MP0005166_decreased_susceptibility_to | 2.21917900 |
| 15 | MP0000685_abnormal_immune_system | 2.21699621 |
| 16 | MP0001873_stomach_inflammation | 2.21573305 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.21570082 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.21414447 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.20598026 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.12286757 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 2.09318074 |
| 22 | MP0006082_CNS_inflammation | 2.08298239 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.03574605 |
| 24 | MP0004858_abnormal_nervous_system | 2.03510944 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.00928805 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.98148719 |
| 27 | MP0002419_abnormal_innate_immunity | 1.93462043 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.92374849 |
| 29 | MP0002723_abnormal_immune_serum | 1.86500687 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.83653752 |
| 31 | MP0001819_abnormal_immune_cell | 1.82695698 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.81191653 |
| 33 | MP0005360_urolithiasis | 1.80452586 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.75506118 |
| 35 | MP0001663_abnormal_digestive_system | 1.73373964 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.68791132 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.66690799 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.66198809 |
| 39 | MP0004947_skin_inflammation | 1.64260999 |
| 40 | MP0005310_abnormal_salivary_gland | 1.55047430 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.53323035 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.52827971 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.43719171 |
| 44 | MP0008004_abnormal_stomach_pH | 1.38195483 |
| 45 | MP0003075_altered_response_to | 1.36765887 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.35541169 |
| 47 | MP0003448_altered_tumor_morphology | 1.32413943 |
| 48 | MP0005381_digestive/alimentary_phenotyp | 1.29895255 |
| 49 | MP0000490_abnormal_crypts_of | 1.29709276 |
| 50 | MP0001664_abnormal_digestion | 1.28886097 |
| 51 | MP0000716_abnormal_immune_system | 1.27357388 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.26786310 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.25901058 |
| 54 | MP0000604_amyloidosis | 1.25458660 |
| 55 | MP0000477_abnormal_intestine_morphology | 1.25073311 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.22364716 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.19852737 |
| 58 | MP0009840_abnormal_foam_cell | 1.19175162 |
| 59 | MP0000343_altered_response_to | 1.18733399 |
| 60 | MP0003329_amyloid_beta_deposits | 1.16922242 |
| 61 | MP0005023_abnormal_wound_healing | 1.16805151 |
| 62 | MP0009764_decreased_sensitivity_to | 1.16583634 |
| 63 | MP0002405_respiratory_system_inflammati | 1.15902294 |
| 64 | MP0005275_abnormal_skin_tensile | 1.15641160 |
| 65 | MP0002933_joint_inflammation | 1.15350329 |
| 66 | MP0008469_abnormal_protein_level | 1.14563738 |
| 67 | MP0002398_abnormal_bone_marrow | 1.13604692 |
| 68 | MP0004510_myositis | 1.11971901 |
| 69 | MP0003045_fibrosis | 1.08527648 |
| 70 | MP0002006_tumorigenesis | 1.08010446 |
| 71 | MP0003279_aneurysm | 1.06808646 |
| 72 | MP0005365_abnormal_bile_salt | 1.02779075 |
| 73 | MP0005390_skeleton_phenotype | 0.99620443 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.99406597 |
| 75 | MP0002429_abnormal_blood_cell | 0.98696524 |
| 76 | MP0005503_abnormal_tendon_morphology | 0.98430026 |
| 77 | MP0009278_abnormal_bone_marrow | 0.97533633 |
| 78 | MP0000858_altered_metastatic_potential | 0.96692002 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.95889784 |
| 80 | MP0000678_abnormal_parathyroid_gland | 0.90603202 |
| 81 | MP0000249_abnormal_blood_vessel | 0.90229297 |
| 82 | MP0005164_abnormal_response_to | 0.89133809 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.87131050 |
| 84 | MP0000681_abnormal_thyroid_gland | 0.86775406 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.86564990 |
| 86 | MP0002796_impaired_skin_barrier | 0.86551255 |
| 87 | MP0005165_increased_susceptibility_to | 0.86513185 |
| 88 | MP0002722_abnormal_immune_system | 0.83995669 |
| 89 | MP0002277_abnormal_respiratory_mucosa | 0.83719579 |
| 90 | MP0001851_eye_inflammation | 0.80765963 |
| 91 | MP0005451_abnormal_body_composition | 0.78442308 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.77099027 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.76914936 |
| 94 | MP0008260_abnormal_autophagy | 0.76905834 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.76893734 |
| 96 | MP0003252_abnormal_bile_duct | 0.76655238 |
| 97 | MP0003828_pulmonary_edema | 0.76146211 |
| 98 | MP0005409_darkened_coat_color | 0.75884094 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.74841177 |
| 100 | MP0001958_emphysema | 0.74278623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.47655221 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.29414039 |
| 3 | Malnutrition (HP:0004395) | 5.03079964 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.87459470 |
| 5 | Prostate neoplasm (HP:0100787) | 4.14299115 |
| 6 | Abnormality of complement system (HP:0005339) | 3.95436753 |
| 7 | Glomerulonephritis (HP:0000099) | 3.83119039 |
| 8 | Vasculitis (HP:0002633) | 3.81068808 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.75042778 |
| 10 | Recurrent bronchitis (HP:0002837) | 3.69187281 |
| 11 | Complement deficiency (HP:0004431) | 3.67151522 |
| 12 | Cellulitis (HP:0100658) | 3.36579414 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.34627352 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.33152276 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 3.29991602 |
| 16 | Colitis (HP:0002583) | 3.25135878 |
| 17 | Meningitis (HP:0001287) | 3.24233924 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.17222662 |
| 19 | Myositis (HP:0100614) | 3.16643042 |
| 20 | Abnormality of the prostate (HP:0008775) | 3.15327751 |
| 21 | Nephritis (HP:0000123) | 3.14790159 |
| 22 | Orchitis (HP:0100796) | 3.12454768 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07657818 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.05601042 |
| 25 | Osteomyelitis (HP:0002754) | 3.05224365 |
| 26 | Premature loss of primary teeth (HP:0006323) | 2.99704027 |
| 27 | Inflammation of the large intestine (HP:0002037) | 2.99475926 |
| 28 | Abnormality of the nasal mucosa (HP:0000433) | 2.97819182 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 2.97720047 |
| 30 | Chronic diarrhea (HP:0002028) | 2.95371000 |
| 31 | Hyperactive renin-angiotensin system (HP:0000841) | 2.89582830 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89001322 |
| 33 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.85845432 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.85026855 |
| 35 | Abnormality of B cell number (HP:0010975) | 2.84116977 |
| 36 | Gingivitis (HP:0000230) | 2.83071741 |
| 37 | Skin rash (HP:0000988) | 2.81106934 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.79408758 |
| 39 | Leukocytosis (HP:0001974) | 2.74728004 |
| 40 | Obstructive lung disease (HP:0006536) | 2.73491615 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73491615 |
| 42 | Chronic otitis media (HP:0000389) | 2.71414477 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.70145437 |
| 44 | Urticaria (HP:0001025) | 2.65606235 |
| 45 | Hemoptysis (HP:0002105) | 2.61571127 |
| 46 | Decreased circulating renin level (HP:0003351) | 2.59198067 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.53951181 |
| 48 | Emphysema (HP:0002097) | 2.52724559 |
| 49 | Increased IgE level (HP:0003212) | 2.48914019 |
| 50 | Optic neuritis (HP:0100653) | 2.47229353 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.47229353 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.44725125 |
| 53 | Recurrent viral infections (HP:0004429) | 2.44582397 |
| 54 | Villous atrophy (HP:0011473) | 2.43388421 |
| 55 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.43388421 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.35078556 |
| 57 | Recurrent skin infections (HP:0001581) | 2.30760023 |
| 58 | Recurrent pneumonia (HP:0006532) | 2.30465761 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.27660902 |
| 60 | Nasal polyposis (HP:0100582) | 2.26640384 |
| 61 | Bronchitis (HP:0012387) | 2.25878102 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.22209762 |
| 63 | Ileus (HP:0002595) | 2.22033485 |
| 64 | Purpura (HP:0000979) | 2.20166325 |
| 65 | Metabolic alkalosis (HP:0200114) | 2.19129353 |
| 66 | Alkalosis (HP:0001948) | 2.14813811 |
| 67 | Chest pain (HP:0100749) | 2.14750201 |
| 68 | Pustule (HP:0200039) | 2.14472041 |
| 69 | Autoimmune thrombocytopenia (HP:0001973) | 2.13870463 |
| 70 | Increased IgM level (HP:0003496) | 2.13583469 |
| 71 | Restrictive lung disease (HP:0002091) | 2.12970072 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 2.11692815 |
| 73 | Polycythemia (HP:0001901) | 2.11644792 |
| 74 | Hematochezia (HP:0002573) | 2.11379785 |
| 75 | B lymphocytopenia (HP:0010976) | 2.11094446 |
| 76 | Recurrent lower respiratory tract infections (HP:0002783) | 2.09586261 |
| 77 | Abnormality of renin-angiotensin system (HP:0000847) | 2.05994456 |
| 78 | Papilloma (HP:0012740) | 2.03326851 |
| 79 | Verrucae (HP:0200043) | 2.03326851 |
| 80 | Peritonitis (HP:0002586) | 2.02492312 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.01266584 |
| 82 | Encephalitis (HP:0002383) | 2.01082551 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.00297813 |
| 84 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99079386 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99079386 |
| 86 | Ankyloglossia (HP:0010296) | 1.98230183 |
| 87 | Skin ulcer (HP:0200042) | 1.96361219 |
| 88 | Abnormality of T cell number (HP:0011839) | 1.96193563 |
| 89 | Sepsis (HP:0100806) | 1.96147264 |
| 90 | Neoplasm of the lung (HP:0100526) | 1.95202692 |
| 91 | Abnormality of the pleura (HP:0002103) | 1.92795483 |
| 92 | Abnormality of the peritoneum (HP:0002585) | 1.91184885 |
| 93 | Gingival bleeding (HP:0000225) | 1.91035149 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 1.88255114 |
| 95 | Lymphopenia (HP:0001888) | 1.86603828 |
| 96 | Pulmonary embolism (HP:0002204) | 1.85108940 |
| 97 | Fragile skin (HP:0001030) | 1.83857515 |
| 98 | Abnormality of male internal genitalia (HP:0000022) | 1.82491864 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 1.80344930 |
| 100 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79967108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.41899989 |
| 2 | MST1R | 3.35258307 |
| 3 | TYK2 | 3.25338134 |
| 4 | MAP4K1 | 3.06225146 |
| 5 | BLK | 2.66614500 |
| 6 | RIPK1 | 2.66099558 |
| 7 | FGFR4 | 2.63338659 |
| 8 | RIPK4 | 2.56323657 |
| 9 | PRPF4B | 2.38954043 |
| 10 | EPHB1 | 2.15545880 |
| 11 | EPHA3 | 2.12409502 |
| 12 | ZAP70 | 1.93801659 |
| 13 | JAK3 | 1.91705751 |
| 14 | CDC42BPA | 1.82825123 |
| 15 | IKBKE | 1.80717010 |
| 16 | KIT | 1.79708706 |
| 17 | JAK1 | 1.77687284 |
| 18 | CSK | 1.69793222 |
| 19 | IRAK4 | 1.68723338 |
| 20 | PIK3CA | 1.67947884 |
| 21 | GRK6 | 1.55354278 |
| 22 | FES | 1.50337680 |
| 23 | MAP3K1 | 1.47071442 |
| 24 | FGFR3 | 1.44295993 |
| 25 | ACVR1B | 1.40812493 |
| 26 | EPHA2 | 1.38592792 |
| 27 | TXK | 1.34563239 |
| 28 | PRKG2 | 1.34040821 |
| 29 | TBK1 | 1.29694491 |
| 30 | JAK2 | 1.26582756 |
| 31 | EPHB2 | 1.26204966 |
| 32 | MAP3K14 | 1.24470344 |
| 33 | SYK | 1.23329674 |
| 34 | MAP3K10 | 1.22910973 |
| 35 | LYN | 1.20336217 |
| 36 | TGFBR2 | 1.18114400 |
| 37 | PTK6 | 1.12036657 |
| 38 | IRAK1 | 1.11742097 |
| 39 | MATK | 1.10905311 |
| 40 | MET | 1.10162774 |
| 41 | STK39 | 1.07273669 |
| 42 | TAOK1 | 1.02412591 |
| 43 | BTK | 0.99124842 |
| 44 | DDR2 | 0.97986139 |
| 45 | FER | 0.97844288 |
| 46 | MAP3K3 | 0.97796063 |
| 47 | MAP3K11 | 0.97520099 |
| 48 | SIK3 | 0.95328551 |
| 49 | HCK | 0.91624500 |
| 50 | MAP2K3 | 0.90974142 |
| 51 | OXSR1 | 0.89036969 |
| 52 | TRIB3 | 0.88264425 |
| 53 | PDGFRA | 0.87901973 |
| 54 | CSF1R | 0.86171524 |
| 55 | NLK | 0.81651964 |
| 56 | PKN2 | 0.80642984 |
| 57 | LCK | 0.79131235 |
| 58 | YES1 | 0.78911205 |
| 59 | LMTK2 | 0.78338328 |
| 60 | STK24 | 0.74215551 |
| 61 | IRAK3 | 0.73137660 |
| 62 | BMPR2 | 0.71913747 |
| 63 | FGR | 0.70504463 |
| 64 | PDPK1 | 0.69920053 |
| 65 | MAP3K12 | 0.68822504 |
| 66 | TESK2 | 0.68102108 |
| 67 | KSR2 | 0.67070051 |
| 68 | FYN | 0.66948304 |
| 69 | MAP3K13 | 0.66282010 |
| 70 | MYLK | 0.66080000 |
| 71 | RET | 0.64897078 |
| 72 | MAP3K6 | 0.60395358 |
| 73 | ADRBK2 | 0.59531019 |
| 74 | ITK | 0.59464286 |
| 75 | MAP3K2 | 0.58338499 |
| 76 | PDK1 | 0.54097103 |
| 77 | BMX | 0.53882500 |
| 78 | LRRK2 | 0.53307802 |
| 79 | KDR | 0.52624851 |
| 80 | TNK2 | 0.52415242 |
| 81 | MAPKAPK2 | 0.50493421 |
| 82 | HIPK2 | 0.49355247 |
| 83 | MAPK7 | 0.49006768 |
| 84 | MAPK11 | 0.48458005 |
| 85 | SMG1 | 0.47907069 |
| 86 | PDGFRB | 0.47800033 |
| 87 | MAP2K2 | 0.46108957 |
| 88 | IKBKB | 0.43698211 |
| 89 | TESK1 | 0.41192022 |
| 90 | TAOK2 | 0.38055349 |
| 91 | SRC | 0.36498042 |
| 92 | MAP2K6 | 0.35986262 |
| 93 | PAK4 | 0.34506524 |
| 94 | CDK6 | 0.34335318 |
| 95 | PRKCQ | 0.33186194 |
| 96 | TEC | 0.33156081 |
| 97 | PRKD2 | 0.32486518 |
| 98 | TAOK3 | 0.32245769 |
| 99 | ADRBK1 | 0.32055823 |
| 100 | DYRK1B | 0.31961195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.76496847 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.54657337 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.17704971 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.05036720 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.01229715 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.84890378 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.65122490 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55293074 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.55008949 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.44083694 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.18149206 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11072901 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.87931182 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.67188185 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65793409 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.60843381 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.60604955 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55334499 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52122185 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50302330 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49743730 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47364411 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.42965966 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39891247 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37066118 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.29082654 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27505256 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.24267553 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.21086602 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14475213 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08495293 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06802839 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.05526757 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04916371 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02527751 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01799756 |
| 37 | Mineral absorption_Homo sapiens_hsa04978 | 1.01230162 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01145442 |
| 39 | Malaria_Homo sapiens_hsa05144 | 0.99249089 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98175404 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97310214 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93495648 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93168491 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.90601611 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89690706 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89081182 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86317733 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86248278 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84997504 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82550595 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82019753 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81771317 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79392706 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77629393 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73595913 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.72755143 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70470232 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69155203 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68061887 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67402964 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.64622425 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62068630 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.62043621 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61817473 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60447680 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59974579 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.58530139 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57699348 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57374395 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56413968 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56324514 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53585454 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50205503 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49753959 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49327845 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48571124 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45630500 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.45165968 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45081278 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.44377034 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43749230 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42824951 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42143274 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41271143 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.41235680 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35370406 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35117980 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.34383843 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34262951 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33862579 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32745355 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.32549322 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31174732 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.29962024 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.28994491 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28627123 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28101886 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.27876192 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27346009 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25126839 |

